Peer Support in Diabetes Management - Insulin Peer Support

NCT03437525 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 360

Last updated 2019-05-22

No results posted yet for this study

Summary

This project will develop a combined model of the Shanghai Integration Model and peer support for diabetes self-management with a special focus on appropriate insulin use.

Conditions

  • Type 2 Diabetes Treated With Insulin

Interventions

BEHAVIORAL

Peer Support

The intervention involves monthly education/support groups co-led by a CHC doctor / nurse and peer coaches. These meetings will begin with a general discussion about participants' previous month, what they had been doing, any special events etc. Meetings will devote time to identifying goals and specific plans for reaching them, rehearsal and/or discussion of specific behaviors to execute plans and ways in which the group members can be helpful to each other. This will be organized around a Diabetes Action Plan. Peer coaches will provide education and support for insulin therapy to help reduce barriers around insulin use. Peer coaches will also organize activities to promote healthy lifestyles, such as walking groups, to promote informal contacts among peer supporters and participants.

Sponsors & Collaborators

  • University of North Carolina, Chapel Hill

    collaborator OTHER
  • Asian Center for Health Education

    collaborator OTHER
  • Shanghai Municipal Commission of Health and Family Planning

    collaborator OTHER
  • Sanofi

    collaborator INDUSTRY
  • Shanghai 6th People's Hospital

    lead OTHER

Principal Investigators

  • Weiping Jia, MD, PhD · Shanghai 6th People's Hospital

  • Edwin B Fisher, PhD · University of North Carolina, Chapel Hill

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-08
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03437525 on ClinicalTrials.gov